Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00627575 · ClinicalTrials.gov registry record · Phase 1
AED/Statin Interaction Study
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 119
- Enrollment target
NCT00627575 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 119 participants.
The verdict
NCT00627575, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 119 participants
- Enrollment target
Study Summary
This study will evaluate the amount of the cholesterol-lowering drug atorvastatin available in the bloodstream, when taken together with the anti-seizure drugs lamotrigine or phenytoin.
Interventions
- DRUG atorvastatin
- DRUG lamotrigine
- DRUG phenytoin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2008-02-04 |
| Est. Completion | 2008-09-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00627575
The ClinicalTrials.gov registry entry for NCT00627575 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which atorvastatin is the first listed.
NCT00627575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00627575 about?
NCT00627575 is a clinical study titled "AED/Statin Interaction Study". This study will evaluate the amount of the cholesterol-lowering drug atorvastatin available in the bloodstream, when taken together with the anti-seizure drugs lamotrigine or phenytoin.
What is the current status of trial NCT00627575?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 119 participants. The study started on 2008-02-04. Estimated completion is 2008-09-12.
What interventions are being tested in trial NCT00627575?
The interventions under investigation include: atorvastatin (DRUG), lamotrigine (DRUG), phenytoin (DRUG).
Who is sponsoring clinical trial NCT00627575?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.